US Stock MarketDetailed Quotes
LPHM LEE PHARMACEUTICALS
- 0.099000
- 0.0000000.00%
15min DelayClose Jul 28 16:00 ET
409.38KMarket Cap-1178P/E (TTM)
0.000000High0.000000Low0Volume0.000000Open0.099000Pre Close0.00Turnover0.00%Turnover RatioLossP/E (Static)4.14MShares0.25500052wk High0.00P/B409.38KFloat Cap0.06000052wk Low--Dividend TTM4.14MShs Float1.190000Historical High--Div YieldTTM0.00%Amplitude0.000100Historical Low--Avg Price1Lot Size
LEE PHARMACEUTICALS Key Stats
Quarterly+Annual
YOY
| (Q3)Jun 30, 2005 | (Q2)Mar 31, 2005 | (Q1)Dec 31, 2004 | (FY)Sep 30, 2004 | (Q4)Sep 30, 2004 | (Q3)Jun 30, 2004 | (Q2)Mar 31, 2004 | (Q1)Dec 31, 2003 | (FY)Sep 30, 2003 | (Q4)Sep 30, 2003 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 29.96%2.23M | 8.42%2.36M | -22.89%2.18M | -2.57%8.53M | 29.72%2.08M | -23.57%1.72M | -13.70%2.17M | 5.02%2.83M | -5.07%8.76M | -30.94%1.61M |
| Operating revenue | 29.96%2.23M | 8.42%2.36M | -22.89%2.18M | -2.57%8.53M | 29.72%2.08M | -23.57%1.72M | -13.70%2.17M | 5.02%2.83M | -5.07%8.76M | -30.94%1.61M |
| Cost of revenue | 29.52%1.27M | -6.71%1.33M | 28.16%1.73M | 4.70%5.5M | 31.49%1.74M | -27.37%979K | 6.24%1.43M | 9.38%1.35M | 5.06%5.25M | -11.93%1.32M |
| Gross profit | 30.54%966K | 37.50%1.02M | -69.79%445K | -13.46%3.03M | 21.48%345K | -17.87%740K | -36.57%744K | 1.31%1.47M | -17.06%3.51M | -65.53%284K |
| Operating expense | -15.77%849K | -2.85%1.02M | -33.09%1.08M | -11.66%3.91M | 17.66%773K | -15.72%1.01M | -21.46%1.05M | 5.34%1.62M | -2.25%4.42M | -24.13%657K |
| Selling and administrative expenses | -25.87%814K | 10.70%1.02M | -8.48%982K | -7.22%3.87M | -27.55%773K | 12.62%1.1M | -16.06%925K | 4.58%1.07M | 7.84%4.17M | 39.30%1.07M |
| Other operating expenses | 138.89%35K | ---- | -81.62%100K | -84.65%39K | --0 | -140.72%-90K | -46.25%129K | 6.88%544K | -61.46%254K | -510.00%-410K |
| Operating profit | 143.66%117K | 99.68%-1K | -342.36%-637K | 4.79%-874K | -14.75%-428K | 9.15%-268K | -83.43%-310K | -77.78%-144K | -207.02%-918K | -788.10%-373K |
| Net non-operating interest income expense | ||||||||||
| Other net income (expense) | -93.10%10K | 180.00%48K | 394.23%771K | 15.09%473K | 124.82%317K | 95.95%145K | -160.61%-60K | 60.82%156K | 183.20%411K | 124.06%141K |
| Special income (charges) | -93.10%10K | 180.00%48K | 394.23%771K | 15.09%473K | 124.82%317K | 95.95%145K | -160.61%-60K | 60.82%156K | 183.20%411K | 124.06%141K |
| Income before tax | ||||||||||
| Income tax | ||||||||||
| Net income | 100.23%1K | 78.24%-104K | 608.33%85K | -11.32%-1.23M | 60.07%-331K | -95.48%-432K | -582.86%-478K | -25.00%12K | -21.19%-1.1M | -11.13%-829K |
| Net income continuous Operations | 100.23%1K | 78.24%-104K | 608.33%85K | -11.32%-1.23M | 60.07%-331K | -95.48%-432K | -582.86%-478K | -25.00%12K | -21.19%-1.1M | -11.13%-829K |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 100.23%1K | 78.24%-104K | 608.33%85K | -11.32%-1.23M | 60.07%-331K | -95.48%-432K | -582.86%-478K | -25.00%12K | -21.19%-1.1M | -11.13%-829K |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 100.23%1K | 78.24%-104K | 608.33%85K | -11.32%-1.23M | 60.07%-331K | -95.48%-432K | -582.86%-478K | -25.00%12K | -21.19%-1.1M | -11.13%-829K |
| Basic earnings per share | 100.22%0.0002 | 81.82%-0.02 | 589.18%0.02 | -11.11%-0.3 | 60.00%-0.08 | -120.00%-0.11 | -450.00%-0.11 | -21.16%0.0029 | -22.73%-0.27 | -11.11%-0.2 |
| Diluted earnings per share | 100.22%0.0002 | 81.82%-0.02 | 589.18%0.02 | -11.11%-0.3 | 60.00%-0.08 | -120.00%-0.11 | -450.00%-0.11 | -21.16%0.0029 | -22.73%-0.27 | -11.11%-0.2 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg